Module 6 · Innovation Layer

Patent Intelligence

Turn research into IP — prior-art search, novelty & inventive-step scoring, patent-landscape mapping, white-space and commercial opportunity.

FTO: preliminary clear
Novelty
vs prior art
Inventive stepLikelynon-obvious combo
Competitor patents23in adjacent space
White-spaces32 commercial

Patent landscape — EGCG / Neem / OSCC

crowded = red, open = green
EGCG anticancer (generic)
Crowded · 140+ filings
Green-tea cosmetics
Crowded · 90+ filings
Neem anti-inflammatory
Moderate · 30 filings
EGCG+Neem oral film
Open white-space

Patent leads

Commercial 90Novelty 0.88FTO clear

Mucoadhesive oral film co-delivering EGCG + Neem flavonoids for oral pre-cancer

Composition + delivery-form claim. No blocking art on the specific combination in a buccal film. Strong product pathway.

Claim: compositionClaim: dosage formClaim: method of use
Patentability
View prior art (12)
Commercial 64Novelty 0.79

Nano-encapsulated EGCG formulation with enhanced buccal bioavailability

Adjacent art exists on nano-EGCG generally; novelty rests on the buccal-targeting excipient system.

Patentability
Narrow claims